324 related articles for article (PubMed ID: 18275907)
1. Strategies and tactics for optimizing the Hit-to-Lead process and beyond--a computational chemistry perspective.
Manly CJ; Chandrasekhar J; Ochterski JW; Hammer JD; Warfield BB
Drug Discov Today; 2008 Feb; 13(3-4):99-109. PubMed ID: 18275907
[TBL] [Abstract][Full Text] [Related]
2. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
3. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
Rester U
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
[TBL] [Abstract][Full Text] [Related]
4. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective.
Zhao H
Drug Discov Today; 2007 Feb; 12(3-4):149-55. PubMed ID: 17275735
[TBL] [Abstract][Full Text] [Related]
5. Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaigns.
Cloutier LM; Sirois S
Drug Discov Today; 2008 Jun; 13(11-12):536-42. PubMed ID: 18549981
[TBL] [Abstract][Full Text] [Related]
6. Hit discovery and hit-to-lead approaches.
Keseru GM; Makara GM
Drug Discov Today; 2006 Aug; 11(15-16):741-8. PubMed ID: 16846802
[TBL] [Abstract][Full Text] [Related]
7. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
8. Looking forward in pharmaceutical process chemistry.
Davies IW; Welch CJ
Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
[TBL] [Abstract][Full Text] [Related]
9. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
Snowden M; Green DV
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
[TBL] [Abstract][Full Text] [Related]
10. Timely synthetic support for medicinal chemists.
Potoski J
Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
[TBL] [Abstract][Full Text] [Related]
11. Image-based chemical screening.
Carpenter AE
Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
[TBL] [Abstract][Full Text] [Related]
12. Maximizing discovery efficiency with a computationally driven fragment approach.
Moore WR
Curr Opin Drug Discov Devel; 2005 May; 8(3):355-64. PubMed ID: 15892251
[TBL] [Abstract][Full Text] [Related]
13. The graphical representation of ADME-related molecule properties for medicinal chemists.
Ritchie TJ; Ertl P; Lewis R
Drug Discov Today; 2011 Jan; 16(1-2):65-72. PubMed ID: 21074634
[TBL] [Abstract][Full Text] [Related]
14. Basic overview of chemoinformatics.
Engel T
J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169
[TBL] [Abstract][Full Text] [Related]
15. Chemogenomics: drug discovery's panacea?
Jacoby E
Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939
[TBL] [Abstract][Full Text] [Related]
16. Integration of virtual and high-throughput screening.
Bajorath J
Nat Rev Drug Discov; 2002 Nov; 1(11):882-94. PubMed ID: 12415248
[TBL] [Abstract][Full Text] [Related]
17. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
18. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
Fischer HP; Heyse S
Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
[TBL] [Abstract][Full Text] [Related]
19. Computational chemistry-driven decision making in lead generation.
Schnecke V; Boström J
Drug Discov Today; 2006 Jan; 11(1-2):43-50. PubMed ID: 16478690
[TBL] [Abstract][Full Text] [Related]
20. Handing over the baton: connecting medicinal chemistry with process R&D.
Federsel HJ
Drug News Perspect; 2008 May; 21(4):193-9. PubMed ID: 18560618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
